Comparative proteome analysis of TGF-β1-induced fibrosis processes in normal rat kidney interstitial fibroblast cells in response to ascofuranone

Proteomics

Volumn 9, Issue 19, 2009, Pages 4445-4456

  Kang, Jeong Han ^a,d   Cho, Hyun Ji ^a   Lee, In Seon ^b   Moonkyu, Kim ^c   Lee, In Kyu ^c   Chang, Young Chae ^a  

^a Catholic University of Daegu   (South Korea)

^b Keimyung University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

2 DE; Cell biology; Fibrosis; Plasminogen activator inhibitor 1

Indexed keywords

ASCOFURANONE; EPIDERMAL GROWTH FACTOR RECEPTOR; FURANONE DERIVATIVE; GLUTAMATE FORMIMINOTRANSFERASE; LASP 1 PROTEIN; LIM PROTEIN; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXIREDOXIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PORPHOBILINOGEN DEAMINASE; PROHIBITIN; PROTEIN DERIVATIVE; PROTEOME; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; FIBROBLAST; FIBROSIS; KIDNEY CELL; KIDNEY INTERSTITIUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; SWISS-PROT; UNINDEXED SEQUENCE;

ANIMALS; CELL LINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FIBROSIS; KIDNEY; MAP KINASE KINASE KINASES; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOME; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SESQUITERPENES; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 70350244839     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800941     Document Type: Article

References (42)

1. Leask, A., Abraham, D. J., TGF-beta signaling and the fibrotic response. FASEB J. 2004, 18, 816-827.
2. Massague, J., TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67, 753-791.
3. Piek, E., Heldin, C. H., Ten Dijke, P., Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 1999, 13, 2105-2124.
4. Kopp, J. B., Factor, V. M., Mozes, M., Nagy, P. et al., Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab. Invest. 1996, 74, 991-1003. (Pubitemid 26182412)
5. Bruzdzinski, C. J., Riordan-Johnson, M., Nordby, E. C., Suter, S. M., Gelehrter, T. D., Isolation and characterization of the rat plasminogen activator inhibitor-1 gene. J. Biol. Chem. 1990, 265, 2078-2085. (Pubitemid 20248311)
6. Keeton, M. R., Curriden, S. A., van Zonneveld, A. J., Loskutoff, D. J., Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J. Biol. Chem. 1991, 266, 23048-23052.
7. Laiho, M., Keski-Oja, J., Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res. 1989, 49, 2533-2553. (Pubitemid 19143375)
8. Pollanen, J., Hedman, K., Nielsen, L. S., Dano, K., Vaheri, A., Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J. Cell. Biol. 1988, 106, 87-95. (Pubitemid 18051396)
9. Rondeau, E. S. J., Schleuning, W. D., The Renal Plasminogen Activating System, in: Molecular Nephrology, Marcel Dekker, New York 1995.
10. Eitzman, D. T., Ginsburg, D., Of mice and men. The function of plasminogen activator inhibitors (PAIs) in vivo. Adv. Exp. Med. Biol. 1997, 425, 131-141. (Pubitemid 28035778)
11. Xu, Y., Hagege, J., Mougenot, B., Sraer, J. D. et al., Different expressions of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int. 1996, 50, 2011-2019. (Pubitemid 26417544)
12. Moll, S., Menoud, P. A., Fulpius, T., Pastore, Y. et al., Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis. Kidney Int. 1995, 48, 1459-1468.
13. Kitching, A. R., Holdsworth, S. R., Ploplis, V. A., Plow, E. F. et al., Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J. Exp. Med. 1997, 185, 963-968.
14. Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., Border, W. A., Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA 1993, 90, 1814-1818. (Pubitemid 23069947)
15. Sasaki, H., Hosokawa, T., Sawada, M., Ando, K., Isolation and structure of ascofuranone and ascofranol, antibiotics with hypolipidemic activity. J. Antibiot. (Tokyo) 1973, 26, 676-680.
16. Magae, J., Hayasaki, J., Matsuda, Y., Hotta, M. et al., Anti-tumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes. J. Antibiot. (Tokyo) 1988, 41, 959-965. (Pubitemid 18186474)
17. Cho, H. J., Kang, J. H., Kwak, J. Y., Lee, T. S. et al., Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK and Ap1-dependent mechanisms. Carcinogenesis 2006, 28, 1104-1110.
18. Magae, J., Suzuki, S., Nagai, K., Yamasaki, M. et al., In vitro effects of an antitumor antibiotic, ascofuranone, on the murine immune system. Cancer Res. 1986, 46, 1073-1078. (Pubitemid 16048232)
19. Kang, J. H., Park, K. K., Lee, I. S., Magae, J. et al., Proteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MS. J. Proteome Res. 2006, 5, 2620-2631. (Pubitemid 44595164)
20. Neuhoff, V., Arold, N., Taube, D., Ehrhardt, W., Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988, 9, 255-262. (Pubitemid 18152745)
21. Kang, J. H., Kim, H. T., Choi, M. S., Lee, W. H. et al., Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics 2006, 6, 1261-1273.
22. Grotendorst, G. R., Okochi, H., Hayashi, N., A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 1996, 7, 469-480. (Pubitemid 26362091)
23. Guo, W., Xu, H., Chen, J., Yang, Y. et al., Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1. Mol. Cell. Biochem. 2007, 295, 167-177. (Pubitemid 46157999)
24. Samarakoon, R., Higgins, S. P., Higgins, C. E., Higgins, P. J., TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling. J. Mol. Cell. Cardiol. 2008, 44, 527-538.
25. Annes, J. P., Munger, J. S., Rifkin, D. B., Making sense of latent TGFbeta activation. J. Cell. Sci. 2003, 116, 217-224.
26. Schoonjans, K., Staels, B., Auwerx, J., The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1996, 1302, 93-109. (Pubitemid 26247079)
27. Clark, R. B., The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 2002, 71, 388-400.
28. Marx, N., Sukhova, G., Murphy, C., Libby, P., Plutzky, J., Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am. J. Pathol. 1998, 153, 17-23. (Pubitemid 28317502)
29. Tsubouchi, Y., Sano, H., Kawahito, Y., Mukai, S. et al., Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem. Biophys. Res. Commun. 2000, 270, 400-405. (Pubitemid 30446848)
30. Ma, L. J., Marcantoni, C., Linton, M. F., Fazio, S., Fogo, A. B., Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int. 2001, 59, 1899-1910. (Pubitemid 32336806)
31. Panchapakesan, U., Sumual, S., Pollock, C. A., Chen, X., PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am. J. Physiol. Renal. Physiol. 2005, 289, F1153-F1158. (Pubitemid 41447072)
32. Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., Springer, T. A., Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986, 137, 245-254. (Pubitemid 16100296)
33. Kawasaki, K., Yaoita, E., Yamamoto, T., Tamatani, T. et al., Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J. Immunol. 1993, 150, 1074-1083. (Pubitemid 23133688)
34. Wada, J., Shikata, K., Makino, H., Morioka, S. et al., The critical role of intercellular adhesion molecule-1 in Masugi nephritis in rats. Nephron 1996, 73, 264-272. (Pubitemid 26159346)
35. Kelly, K. J., Williams, W. W., Jr., Colvin, R. B., Meehan, S. M. et al., Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. 1996, 97, 1056-1063. (Pubitemid 26070586)
36. Okada, S., Shikata, K., Matsuda, M., Ogawa, D. et al., Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 2003, 52, 2586-2593. (Pubitemid 37210549)
37. Rerolle, J. P., Hertig, A., Nguyen, G., Sraer, J. D., Rondeau, E. P., Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int. 2000, 58, 1841-1850. (Pubitemid 30807911)
38. Poggi, M., Paulmyer-Lacroix, O., Verdier, M., Peiretti, F. et al., Chronic plasminogen activator inhibitor-1 (PAI-1) overexpression dampens CD25+lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung. J. Thromb. Haemost. 2007, 5, 2467-2475. (Pubitemid 350154358)
39. Izuhara, Y., Takahashi, S., Nangaku, M., Takizawa, S. et al., Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 672-677. (Pubitemid 351651332)
40. Chuang-Tsai, S., Sisson, T. H., Hattori, N., Tsai, C. G. et al., Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. Am. J. Pathol. 2003, 163, 445-452. (Pubitemid 36909408)
41. Swiatkowska, M., Szemraj, J., Cierniewski, C. S., Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G/5G site. FEBS J. 2005, 272, 5821-5831. (Pubitemid 41689354)
42. Li, X., Kimura, H., Hirota, K., Kasuno, K. et al., Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells. Kidney Int. 2005, 68, 569-583. (Pubitemid 43323112)